Biogen's (BIIB) Big Moves Signal Future Sale
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Biogen Reports Second Quarter 2016 Revenues of $2.9 Billion
July 21, 2016 7:00 AM EDTSecond quarter 2016 GAAP diluted EPS rise 22%; Non-GAAP diluted EPS rise 23%
Company raises financial guidance for the year and authorizes $5 billion share repurchase program
George A. Scangos, Ph.D., to step down as CEO
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) today reported second quarter 2016 financial results, including:
Total revenues of $2.9 billion, a 12% increase versus the same period in the prior year. Growth was driven by increases in worldwide revenues from the Companys multiple sclerosis (MS) and hemophilia... More